The role of inflammation in epilepsy
暂无分享,去创建一个
Tallie Z. Baram | Annamaria Vezzani | T. Baram | T. Bártfai | J. French | A. Vezzani | Tamas Bartfai | Jacqueline French
[1] James O. McNamara,et al. Formation of Complement Membrane Attack Complex in Mammalian Cerebral Cortex Evokes Seizures and Neurodegeneration , 2003, The Journal of Neuroscience.
[2] T. Baram,et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. , 1996, Pediatrics.
[3] W. Banks,et al. The blood–brain barrier and immune function and dysfunction , 2010, Neurobiology of Disease.
[4] H. Cross,et al. Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. , 2007, The Cochrane database of systematic reviews.
[5] T. Bártfai,et al. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. , 2008, Brain : a journal of neurology.
[6] T. Cullingford. Peroxisome proliferator‐activated receptor alpha and the ketogenic diet , 2008, Epilepsia.
[7] M Locati,et al. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. , 2001, Trends in immunology.
[8] E. Benveniste,et al. SOCS1 and SOCS3 in the control of CNS immunity. , 2009, Trends in immunology.
[9] A. Nehlig,et al. Temporal patterns of the cerebral inflammatory response in the rat lithium–pilocarpine model of temporal lobe epilepsy , 2004, Neurobiology of Disease.
[10] F. Gardoni,et al. Cytokines and neuronal ion channels in health and disease. , 2007, International review of neurobiology.
[11] David A. Willoughby,et al. Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxinsin vivo andin vitro , 1994, Neuroscience.
[12] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[13] A. Vezzani,et al. Age-dependent vascular changes induced by status epilepticus in rat forebrain: Implications for epileptogenesis , 2009, Neurobiology of Disease.
[14] E. Aronica,et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex , 2008, Epilepsy Research.
[15] T. Fujiwara,et al. A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFα, and Granzyme B in CSF , 2009, Epilepsia.
[16] G. Sperk,et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Henriksen,et al. Profound increase in sensitivity to glutamatergic‐ but not cholinergic agonist‐induced seizures in transgenic mice with astrocyte production of IL‐6 , 2003, Journal of neuroscience research.
[18] E. Aronica,et al. Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy , 2009, Epilepsy Research.
[19] Shlomo Shinnar,et al. Infantile spasms: A U.S. consensus report , 2010, Epilepsia.
[20] R. Dantzer. Cytokine, sickness behavior, and depression. , 2006, Neurologic clinics.
[21] E. Aronica,et al. The IL-1β system in epilepsy-associated malformations of cortical development , 2006, Neurobiology of Disease.
[22] C. Elger,et al. Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in rasmussen's encephalitis , 2002, Annals of neurology.
[23] J. Julien,et al. Innate immunity: the missing link in neuroprotection and neurodegeneration? , 2002, Nature Reviews Neuroscience.
[24] Moses Rodriguez,et al. Seizures in Patients with Multiple Sclerosis , 2009, CNS drugs.
[25] Marian Joëls,et al. The neuro-symphony of stress , 2009, Nature Reviews Neuroscience.
[26] A. Vezzani,et al. Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1β production , 2008, Neurobiology of Disease.
[27] Q. Pittman,et al. Causal Links between Brain Cytokines and Experimental Febrile Convulsions in the Rat , 2005, Epilepsia.
[28] Alon Friedman,et al. Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury , 2010, Nature Reviews Neurology.
[29] E. Wirrell,et al. The Epileptic Encephalopathies of Infancy and Childhood , 2005, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[30] A. Vezzani,et al. Inactivation of Caspase‐1 in Rodent Brain: A Novel Anticonvulsive Strategy , 2006, Epilepsia.
[31] Amy L. Brewster,et al. Fever, febrile seizures and epilepsy , 2007, Trends in Neurosciences.
[32] Boyoung Lee,et al. CRE-mediated transcription and COX-2 expression in the pilocarpine model of status epilepticus , 2007, Neurobiology of Disease.
[33] R. Riikonen. Topical Review: Infantile Spasms: Therapy and Outcome , 2004 .
[34] T. Bártfai,et al. Ceramide mediates the rapid phase of febrile response to IL-1beta. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Gilmore. Introduction to NF-κB: players, pathways, perspectives , 2006, Oncogene.
[36] 辻江正徳. TGF-β(transforming growth factor-β) , 2002 .
[37] Adam R Ferguson,et al. Cell Death after Spinal Cord Injury Is Exacerbated by Rapid TNFα-Induced Trafficking of GluR2-Lacking AMPARs to the Plasma Membrane , 2008, The Journal of Neuroscience.
[38] E. Oby,et al. The Blood–Brain Barrier and Epilepsy , 2006, Epilepsia.
[39] G. Avanzini,et al. The use of immunoglobulins in the treatment of human epilepsy , 2002, Neurological Sciences.
[40] Quentin J. Pittman,et al. Contributions of peripheral inflammation to seizure susceptibility: Cytokines and brain excitability , 2010, Epilepsy Research.
[41] Xiaoyu Peng,et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies , 2008, The Lancet Neurology.
[42] M. Satoh,et al. Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα and LIF in the rat brain , 1991 .
[43] E. Aronica,et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures , 2010, Nature Medicine.
[44] B. Beutler,et al. Forward genetic analysis of TLR-signaling pathways: an evaluation. , 2008, Advanced drug delivery reviews.
[45] R. Spreafico,et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures , 2002, Journal of Neuroimmunology.
[46] Morris H. Scantlebury,et al. Febrile seizures and temporal lobe epileptogenesis , 2010, Epilepsy Research.
[47] C. Kaltschmidt,et al. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. , 1997, Trends in neurosciences.
[48] P. Bramanti,et al. The emerging role for chemokines in epilepsy , 2010, Journal of Neuroimmunology.
[49] H. Lodish,et al. Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.
[50] Takao Shimizu,et al. Profiling of Eicosanoid Production in the Rat Hippocampus during Kainic Acid-induced Seizure , 2006, Journal of Biological Chemistry.
[51] R. Malenka,et al. Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α , 2005, The Journal of Neuroscience.
[52] S. Appel,et al. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? , 2010, Trends in immunology.
[53] M. Hurme,et al. Increased Plasma Levels of Pro‐ and Anti‐inflammatory Cytokines in Patients with Febrile Seizures , 2002, Epilepsia.
[54] Asla Pitkänen,et al. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy , 2002, The Lancet Neurology.
[55] M. G. Koerkamp,et al. Possible role of the innate immunity in temporal lobe epilepsy , 2008, Epilepsia.
[56] J. Cross,et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis , 2004, Neurology.
[57] T. Bártfai,et al. Interleukin‐1 System in CNS Stress , 2007, Annals of the New York Academy of Sciences.
[58] R. Mennigen,et al. Endocytosis and Recycling of Tight Junction Proteins in Inflammation , 2009, Journal of biomedicine & biotechnology.
[59] J. Schramm,et al. Treatment of Rasmussen encephalitis half a century after its initial description: Promising prospects and a dilemma , 2009, Epilepsy Research.
[60] M. Schwartz,et al. Systemic inflammatory cells fight off neurodegenerative disease , 2010, Nature Reviews Neurology.
[61] C. Plata-salamán,et al. Kindling modulates the IL-1β system, TNF-α, TGF-β1, and neuropeptide mRNAs in specific brain regions , 2000 .
[62] T. Bártfai,et al. IL‐1β induces a MyD88‐dependent and ceramide‐mediated activation of Src in anterior hypothalamic neurons , 2006, Journal of neurochemistry.
[63] J. McNamara,et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. , 1994, Science.
[64] D. Sinclair. Prednisone therapy in pediatric epilepsy. , 2003, Pediatric neurology.
[65] N. Stocchetti,et al. C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice* , 2009, Critical care medicine.
[66] C. Dinarello,et al. Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.
[67] D. Torpy,et al. Stress, Corticotropin‐Releasing Hormone, Glucocorticoids, and the Immune/Inflammatory Response: Acute and Chronic Effects a , 1999, Annals of the New York Academy of Sciences.
[68] T. Baram,et al. New Roles for Interleukin-1 Beta in the Mechanisms of Epilepsy , 2007, Epilepsy currents.
[69] M. Mikati,et al. Intravenous immunoglobulin therapy in intractable childhood epilepsy: Open-label study and review of the literature , 2010, Epilepsy & Behavior.
[70] N. Rothwell. CRF is involved in the pyrogenic and thermogenic effects of interleukin 1 beta in the rat. , 1989, The American journal of physiology.
[71] Q. Pittman,et al. Cytokines and brain excitability , 2012, Frontiers in Neuroendocrinology.
[72] S. Kulkarni,et al. Cyclooxygenase in epilepsy: from perception to application. , 2009, Drugs of Today.
[73] F. Dorandeu,et al. Prolonged inflammatory gene response following soman-induced seizures in mice. , 2007, Toxicology.
[74] K. Frei,et al. Molecular and cellular permeability control at the blood–brain barrier , 2001, Brain Research Reviews.
[75] C. Sommer,et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke , 2009, Nature Medicine.
[76] J. Rosenow,et al. Cellular injury and neuroinflammation in children with chronic intractable epilepsy , 2009, Journal of Neuroinflammation.
[77] C. Dinarello. Review: Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed , 2004, Journal of endotoxin research.
[78] John S Duncan,et al. Adult epilepsy , 2006, The Lancet.
[79] A. Nehlig,et al. Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long-term excitability , 2009, Epilepsy Research.
[80] Tsonwin Hai,et al. Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages. , 2007, Molecular immunology.
[81] A. Vincent,et al. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins , 2010, Current opinion in neurology.
[82] J. Wheless,et al. Treatment of pediatric epilepsy: European expert opinion, 2007. , 2007, Epileptic disorders : international epilepsy journal with videotape.
[83] G. Juhász,et al. Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats , 2006, Neuroscience.
[84] E. Aronica,et al. Brain Inflammation and Epilepsy , 2010 .
[85] J. Osborne,et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial , 2005, The Lancet Neurology.
[86] N. Marklund,et al. Neutralization of interleukin‐1β modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice , 2009, The European journal of neuroscience.
[87] Shuxian Hu,et al. Cytokine Effects on Glutamate Uptake by Human Astrocytes , 2000, Neuroimmunomodulation.
[88] G. Pasinetti,et al. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. , 1999, The American journal of pathology.
[89] Antonio Osculati,et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy , 2008, Nature Medicine.
[90] G. Kollias,et al. CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity , 2001, Nature Neuroscience.
[91] C. Elger,et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy , 2007, Neurology.
[92] K. Katki,et al. Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus , 2009, Journal of Neuroinflammation.
[93] G. SadleirLynette,et al. Febrile seizures , 2007 .
[94] Eleonora Aronica,et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: Evidence from experimental models and human temporal lobe epilepsy , 2008, Neurobiology of Disease.
[95] M. Tsan,et al. Endogenous ligands of Toll‐like receptors , 2004, Journal of leukocyte biology.
[96] L. Mucke,et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[97] E. Vining,et al. The Pathology of Rasmussen Syndrome: Stages of Cortical Involvement and Neuropathological Studies in 45 Hemispherectomies , 2004, Epilepsia.
[98] F. Dudek,et al. Network properties of the dentate gyrus in epileptic rats with hilar neuron loss and granule cell axon reorganization. , 1997, Journal of neurophysiology.
[99] O. Yeǧin,et al. Interleukin-1β, Tumor Necrosis Factor-α, and Nitrite Levels in Febrile Seizures , 2002 .
[100] P. V. van Rijen,et al. Gene Expression Analysis of Tuberous Sclerosis Complex Cortical Tubers Reveals Increased Expression of Adhesion and Inflammatory Factors , 2009, Brain pathology.
[101] D. Jung,et al. Efficacy and prognosis of a short course of prednisolone therapy for pediatric epilepsy. , 2008, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[102] A. Vezzani,et al. Interleukin-1β Immunoreactivity and Microglia Are Enhanced in the Rat Hippocampus by Focal Kainate Application: Functional Evidence for Enhancement of Electrographic Seizures , 1999, The Journal of Neuroscience.
[103] H. Korn,et al. Interleukin-1β induces hyperpolarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons , 2006, Neuroscience.
[104] Giovambattista De Sarro,et al. Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice , 2004, Pharmacology Biochemistry and Behavior.
[105] D. Spencer,et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination , 1993, Annals of neurology.
[106] Q. Pittman,et al. Early Life Activation of Toll-Like Receptor 4 Reprograms Neural Anti-Inflammatory Pathways , 2010, The Journal of Neuroscience.
[107] R. Ransohoff,et al. Three or more routes for leukocyte migration into the central nervous system , 2003, Nature Reviews Immunology.
[108] M. Shapira,et al. Transcriptome Profiling Reveals TGF-β Signaling Involvement in Epileptogenesis , 2009, The Journal of Neuroscience.
[109] G. Rondouin,et al. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis , 2002, Brain Research.
[110] T. Baram,et al. Corticotropin (ACTH) acts directly on amygdala neurons to down‐regulate corticotropin‐releasing hormone gene expression , 2001, Annals of neurology.
[111] S. Akira,et al. Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.
[112] P. Schweitzer,et al. Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus , 2005, Neuropharmacology.
[113] A. Vezzani,et al. Tumor necrosis factor‐α inhibits seizures in mice via p75 receptors , 2005 .
[114] S. Kulkarni,et al. Significantly higher serologic responses of Chlamydia trachomatis B group serovars versus C and I serogroups. , 2009 .
[115] J. Aarli,et al. Epilepsy and the immune system. , 2000, Archives of neurology.
[116] M. Sayyah,et al. The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins , 2003, Neuroscience.
[117] A. Koch,et al. Chemokines and angiogenesis , 2001, Current opinion in rheumatology.
[118] E. Perucca,et al. Development of new antiepileptic drugs: challenges, incentives, and recent advances , 2007, The Lancet Neurology.
[119] O. Devinsky,et al. Immunology and epilepsy. , 2008, Reviews in neurological diseases.
[120] A. Vezzani,et al. The role of cytokines in the pathophysiology of epilepsy , 2008, Brain, Behavior, and Immunity.
[121] B. Litt,et al. Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis. , 2006, Brain : a journal of neurology.
[122] J. C. Baayen,et al. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies , 2010, Neuroscience.
[123] A. Vezzani,et al. Brain Inflammation in Epilepsy: Experimental and Clinical Evidence , 2005, Epilepsia.
[124] Imad Najm,et al. Seizure‐Promoting Effect of Blood–Brain Barrier Disruption , 2007, Epilepsia.
[125] A. Galanopoulou. Epilepsy: Mechanisms, Models, and Translational Perspectives Jong M. Rho , 2011, Epilepsy & Behavior.
[126] N. Perkins,et al. Integrating cell-signalling pathways with NF-κB and IKK function , 2007, Nature Reviews Molecular Cell Biology.
[127] M. Mackay,et al. CME Practice Parameter : Medical Treatment of Infantile Spasms , 2004 .
[128] Asla Pitkänen,et al. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy , 2009, Epilepsy & Behavior.
[129] U. Heinemann,et al. Astrocytic Dysfunction in Epileptogenesis: Consequence of Altered Potassium and Glutamate Homeostasis? , 2009, The Journal of Neuroscience.
[130] G. Teskey,et al. Postnatal Inflammation Increases Seizure Susceptibility in Adult Rats , 2008, The Journal of Neuroscience.
[131] H. Nakanishi,et al. Acute p38-mediated inhibition of NMDA-induced outward currents in hippocampal CA1 neurons by interleukin-1β , 2010, Neurobiology of Disease.
[132] T. Baram,et al. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain , 1998, Trends in Neurosciences.
[133] T. Ichiyama,et al. Tumor necrosis factor‐a, interleukin‐lβ, and interleukin‐6 in cerebrospinal fluid from children with prolonged febrile seizures Comparison with acute encephalitis/encephalopathy , 1998, Neurology.
[134] T. Baram,et al. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. , 2002, International review of neurobiology.
[135] T. Baram,et al. Interleukin‐1β contributes to the generation of experimental febrile seizures , 2005, Annals of neurology.
[136] R. Riikonen. Infantile spasms: therapy and outcome. , 2004, Journal of child neurology.
[137] Wolfgang Löscher,et al. The neurobiology of antiepileptic drugs , 2004, Nature Reviews Neuroscience.
[138] J. Freedman,et al. A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? , 2007, Blood.
[139] G. Kollias,et al. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. , 1997, Journal of immunology.
[140] D. Freshwater. A U , 2002 .
[141] Keun-Hwa Jung,et al. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus , 2006, Neurobiology of Disease.
[142] N. Rothwell,et al. Cytokines and acute neurodegeneration , 1997, Molecular Psychiatry.
[143] E. Aronica,et al. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. , 2007, Brain : a journal of neurology.
[144] C. Kaltschmidt,et al. NF-kB: a crucial transcription factor for glial and neuronal cell function , 1997, Trends in Neurosciences.
[145] M. Mikati,et al. Efficacy of intravenous immunoglobulin in Landau-Kleffner syndrome. , 2002, Pediatric neurology.
[146] D. Sanderson,et al. Malaise in the water maze: Untangling the effects of LPS and IL-1β on learning and memory , 2008, Brain, Behavior, and Immunity.
[147] A. Becker,et al. Molecular profiling of temporal lobe epilepsy: comparison of data from human tissue samples and animal models , 2004, Epilepsy Research.
[148] F. Tang,et al. CCR3, CCR2A and macrophage inflammatory protein (MIP)‐1α, monocyte chemotactic protein‐1 (MCP‐1) in the mouse hippocampus during and after pilocarpine‐induced status epilepticus (PISE) , 2009, Neuropathology and applied neurobiology.
[149] N. Rothwell,et al. Brain sites of action of endogenous interleukin‐1 in the febrile response to localized inflammation in the rat , 1999, The Journal of physiology.
[150] L. Lagae,et al. Steroids in intractable childhood epilepsy: Clinical experience and review of the literature , 2005, Seizure.
[151] S. Garattini,et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus , 2000, The European journal of neuroscience.
[152] L. J. Eldik,et al. Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury , 2008, Journal of Neuroinflammation.
[153] B. Winblad,et al. Increased expression of mRNA encoding interleukin‐1β and caspase‐1, and the secreted isoform of interleukin‐1 receptor antagonist in the rat brain following systemic kainic acid administration , 2000, Journal of neuroscience research.
[154] M. Baybis,et al. Expression of ICAM-1, TNF-α, NFκB, and MAP kinase in tubers of the tuberous sclerosis complex , 2003, Neurobiology of Disease.
[155] N. Bazan,et al. Lipid signaling: sleep, synaptic plasticity, and neuroprotection. , 2005, Prostaglandins & other lipid mediators.
[156] R. Sapolsky,et al. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. , 1987, Science.
[157] P. Maquet,et al. Landau‐Kleffner Syndrome: A Pharmacologic Study of Five Cases , 1990, Epilepsia.
[158] L. Ivashkiv,et al. Lipopolysaccharide-Induced Expression of Matrix Metalloproteinases in Human Monocytes Is Suppressed by IFN-γ via Superinduction of ATF-3 and Suppression of AP-11 , 2008, The Journal of Immunology.
[159] C. Hunter,et al. Trafficking of immune cells in the central nervous system. , 2010, The Journal of clinical investigation.
[160] F. L. D. Silva,et al. Complement activation in experimental and human temporal lobe epilepsy , 2007, Neurobiology of Disease.
[161] N. Rothwell,et al. Interleukin-1 and neuronal injury , 2005, Nature Reviews Immunology.
[162] C L Galli,et al. Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases , 2003, The Journal of Neuroscience.
[163] T. Bártfai,et al. Delineation of the Proinflammatory Cytokine Cascade in Fever Induction a , 1998, Annals of the New York Academy of Sciences.
[164] Kevin J. Tracey,et al. The inflammatory reflex , 2002, Nature.
[165] S. Rivest,et al. Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy , 2004, Neurobiology of Disease.
[166] T. Bártfai,et al. Cytokines in neuronal cell types , 1993, Neurochemistry International.
[167] R. Sankar,et al. Inflammation enhances epileptogenesis in the developing rat brain , 2010, Neurobiology of Disease.
[168] R. Sapolsky,et al. Characterization of monocyte chemoattractant protein-1 expression following a kainate model of status epilepticus , 2007, Brain Research.
[169] T. Holford,et al. Seizures with Fever After Unprovoked Seizures: An Analysis in Children Followed from the Time of a First Febrile Seizure , 1998, Epilepsia.
[170] Wytse J. Wadman,et al. Potential New Antiepileptogenic Targets Indicated by Microarray Analysis in a Rat Model for Temporal Lobe Epilepsy , 2006, The Journal of Neuroscience.
[171] Wolfgang Löscher,et al. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy , 2010, Experimental Neurology.
[172] T. Davis,et al. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.
[173] G. Mathern,et al. Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex , 2009, Neurobiology of Disease.
[174] M. Morganti-Kossmann,et al. Role of Chemokines in CNS Health and Pathology: A Focus on the CCL2/CCR2 and CXCL8/CXCR2 Networks , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[175] A. Obenaus,et al. Epileptogenesis Provoked by Prolonged Experimental Febrile Seizures: Mechanisms and Biomarkers , 2010, The Journal of Neuroscience.
[176] Q. Pittman,et al. Neonatal inflammation produces selective behavioural deficits and alters N‐methyl‐d‐aspartate receptor subunit mRNA in the adult rat brain , 2008, The European journal of neuroscience.
[177] Fred H. Gage,et al. Mechanisms Underlying Inflammation in Neurodegeneration , 2010, Cell.
[178] P. V. van Rijen,et al. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias , 2010, Epilepsia.
[179] J. Velíšková,et al. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development , 2003, Neurobiology of Disease.
[180] K. Laxer,et al. Gene expression analysis reveals altered brain transcription of glutamate receptors and inflammatory genes in a patient with chronic focal (Rasmussen's) encephalitis , 2002, Journal of Neuroimmunology.
[181] Simona Frigerio,et al. Expression of Adhesion Factors Induced by Epileptiform Activity in the Endothelium of the Isolated Guinea Pig Brain In Vitro , 2007, Epilepsia.
[182] X. Zhu,et al. Expression of monocyte chemoattractant protein-1 in brain tissue of patients with intractable epilepsy. , 2008, Clinical neuropathology.
[183] C. Bien,et al. Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults , 2008, The Lancet Neurology.
[184] H. Lodish,et al. Role of Transforming Growth Factor in Human Disease , 2000 .
[185] Y. S. al-Ghamdy,et al. Epidemiology, pathophysiology and management , 2003 .
[186] A. Vezzani,et al. Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system , 2006, Neuroscience.
[187] A. Pitkänen,et al. Epileptogenesis-related genes revisited. , 2006, Progress in brain research.